Vimarsana
Biggest News Aggregation in the World

Brandon Monk News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Brandon Monk. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Brandon Monk Today - Breaking & Trending Today

Supervisors OK about $2M in funding for outside agencies - Vimarsana News

Supervisors OK about $2M in funding for outside agencies

During a three-hour budget work session Thursday night, the Frederick County Board of Supervisors reached a consensus on funding for some outside agencies but delayed decisions for Laurel Ridge Community

FDA approves Takeda's self-administered Entyvio for Crohn's disease - Vimarsana News

FDA approves Takeda's self-administered Entyvio for Crohn's disease

Takeda has announced that the U.S. Food and Drug Administration (FDA) has approved a subcutaneous (SC) version of Entyvio, its treatment for adults with moderate to severe Crohn’s disease (CD).

Subcutaneous Vedolizumab Approved for Moderate-to-Severe Crohn Disease - Vimarsana News

Subcutaneous Vedolizumab Approved for Moderate-to-Severe Crohn Disease

Announced on April 18, the approval is based on the VISIBLE 2 trial and comes less than 7 months after the approval of SC vedolizumab in ulcerative colitis.

Entyvio for Subcutaneous Use Approved for Maintenance in Crohn Disease - Vimarsana News

Entyvio for Subcutaneous Use Approved for Maintenance in Crohn Disease

The approval was based on data from the phase 3 VISIBLE 2 trial.

Source: empr.com
FDA Approves Vedolizumab for Maintenance Therapy to Treat Crohn Disease - Vimarsana News

FDA Approves Vedolizumab for Maintenance Therapy to Treat Crohn Disease

The primary endpoint of the study was clinical remission at week 52 with vedolizumab